Effects of GH and Lirglutide on AgRP

Recruiting Phase 4 Interventional Study
Healthy Growth Hormone Deficiency
Prior Safety Data This treatment has already been tested in at least one earlier human trial. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 45
Sex
Any
Trial phase
Phase 4
Study type
Interventional
Purpose
Other
Participants needed
40 (estimated)
Sponsor
Columbia University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a randomized, placebo-controlled, cross-over study with 4 arms. Healthy and GH deficient adults ages 18-45 years will be studied. Arms will consist of 21-day treatment periods and be separated by 8-week washout periods. Subjects will receive, in random order: i) GH alone, ii) GH with liraglutide, iii) liraglutide alone and iv) placebo. Each phase of the study will consist of a 7-day baseli…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: HEALTHY SUBJECTS 1. 40 healthy subjects, 20 male, 20 female, ages 18-45 yr.: (i) 20 (10 male, 10 female) who are overweight/Class 1 Obese (BMI 25-34.9) with abdominal fat accumulation (central adiposity) defined by waist circumference (WC) ≥ 102 cm in men, ≥ 88 cm in women, exc…
Contacts

Pamela Freda, MD

2123052254

puf1@cumc.columbia.edu

CONTACT

Rosa Lazarte

2123054921

rl2345@cumc.columbia.edu

CONTACT